What i don't understand, including from a chat with one of the Directors (BdK) the other day, is why CFDA is holding up the production from the China production facility. Why can't they start cranking out product and supply MEDTEL to kickstart the Greece/Cyprus contract? Surely that is only governed by CE Mark and the fact the product is manufactured in China is irrelevant. Can anyone lead me in the right direction why CFDA would be required? They seem to indicate in this release it is required.
Having said that, no way i can gamble with this stock presently, because FDA for the Patch could arrive any time which triggers Winola contract and brings into play our new monitoring facility in the US. Winola is a pretty reputable partner. Think the US is going to be big for us.
GMV Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
